Sedana Medical AB (publ) reports record-breaking sales growth in the first quarter of 2018.
Sedana Medical AB ("Sedana Medical or the Company") reports a more than expected 60% increase in sales in the first quarter of 2018 compared to the corresponding period in 2017.During the initial listing Sedana Medical announced a target to increase sales by 20% per year on average until the registration of the pharmaceutical IsoConDa. For the full year 2017, sales increased by 26% compared with 2016. Sales during the first quarter of 2018 amounted to TSEK 15,486 (TSEK 9,681), which is an increase of 60% compared to the corresponding period in 2017. This is more than previously expected.